Sheng-Xiao Zhang | Rheumatology | Research Excellence Award

Research Excellence Award
Sheng-Xiao Zhang — Second Hospital of Shanxi Medical University, China
Sheng-Xiao Zhang
Affiliation Second Hospital of Shanxi Medical University
Country China
Scopus ID 56278352600
Documents 134
Citations 1,703
h-index 23
Subject Area Rheumatology
Event Global Diseases Research Awards
ORCID 0000-0003-1341-7588

Sheng-Xiao Zhang is a clinical researcher affiliated with Second Hospital of Shanxi Medical University, China, with a focus on rheumatology and related autoimmune disorders. His scholarly output reflects consistent contributions to clinical studies, translational research, and evidence-based therapeutic approaches. With extensive indexing in Scopus, his work demonstrates significant citation impact and academic visibility within the global medical community. This article summarizes his research profile, publications, and scholarly influence in rheumatology. It further highlights his suitability for the Research Excellence Award under the Global Diseases Research Awards framework, emphasizing academic productivity, citation metrics, and international research engagement in advancing modern rheumatological science globally recognized.

Abstract

Sheng-Xiao Zhang is a clinical researcher affiliated with Second Hospital of Shanxi Medical University, China, with a focus on rheumatology and related autoimmune disorders. His scholarly output reflects consistent contributions to clinical studies, translational research, and evidence-based therapeutic approaches. With extensive indexing in Scopus, his work demonstrates significant citation impact and academic visibility within the global medical community. This article summarizes his research profile, publications, and scholarly influence in rheumatology. It further highlights his suitability for the Research Excellence Award under the Global Diseases Research Awards framework, emphasizing academic productivity, citation metrics, and international research engagement in advancing modern rheumatological science globally recognized.[1]

Keywords

Rheumatology, Autoimmune diseases, Clinical research, Immunology, Shanxi Medical University, Scopus index, Research excellence, Translational medicine.

Introduction

Sheng-Xiao Zhang is a medical academic specializing in rheumatology at Second Hospital of Shanxi Medical University, China. His research focuses on autoimmune diseases, inflammatory mechanisms, and clinical interventions. He has contributed to advancing evidence-based rheumatology practices, with a strong publication record and international academic engagement across multidisciplinary biomedical research communities worldwide collaboration network.[1]

Research Profile

His research profile encompasses clinical rheumatology, immunology, and translational medicine. He has engaged in studies addressing autoimmune pathophysiology, therapeutic optimization, and patient outcomes. His academic work is indexed in Scopus, reflecting strong visibility and citation performance. He participates in collaborative research initiatives aimed at improving global rheumatologic healthcare standards advancement.[2]

Research Contributions

Zhang’s research contributions include clinical investigations into autoimmune disorders, biomarker identification, and therapeutic response evaluation. He has contributed to peer-reviewed studies improving diagnostic accuracy and treatment strategies in rheumatology. His work supports evidence-based medicine and enhances understanding of inflammatory disease progression within diverse patient populations across international clinical settings globally. [3]

Publications

His publication record includes peer-reviewed articles in rheumatology and related biomedical fields. These works cover autoimmune disease mechanisms, clinical treatment outcomes, and translational research findings. His Scopus-indexed outputs demonstrate consistent scholarly productivity and contribute to the advancement of clinical knowledge in immunological and musculoskeletal disorders within global research databases networks.[4]

Research Impact

His research impact is reflected through citations, collaborative studies, and contributions to advancing rheumatology research. With an h-index of 23 and over 1,700 citations, his work demonstrates significant academic influence. His studies are widely referenced in clinical research, supporting improved understanding of autoimmune disease management across international scientific communities globally.[3]

Award Suitability

Sheng-Xiao Zhang is considered suitable for the Research Excellence Award due to his strong academic record in rheumatology, significant citation impact, and consistent publication output. His contributions to clinical research and international collaboration align with the objectives of the Global Diseases Research Awards recognizing scientific excellence and innovation globally recognized.[1]

Conclusion

This article highlights Sheng-Xiao Zhang’s academic profile, emphasizing his contributions to rheumatology research, clinical advancements, and scientific publications. His work demonstrates significant scholarly impact and international relevance. Continued research engagement is expected to further enhance his contributions to global medical science and rheumatologic innovation in future academic research landscapes globally.

References

1. Elsevier. (n.d.). Scopus author details: Sheng-Xiao Zhang, Author ID 56278352600. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=56278352600

2. Qi, X.-Y., Liu, M.-X., Jiang, X.-J., Gao, T., Xu, G.-Q., Zhang, H.-Y., Su, Q.-Y., Du, Y., Luo, J., & Zhang, S.-X. (2025). Gut microbiota in rheumatoid arthritis: Mechanistic insights, clinical biomarkers, and translational perspectives. Autoimmunity Reviews.
https://doi.org/10.1016/j.autrev.2025.103912

3. Zhang, W., Wang, C., Fu, T., Zhang, S., & Tian, F. (2025). CD4+ T lymphocyte and cytokine profiles in depressive disorders. BMC Psychiatry.
https://doi.org/10.1186/s12888-025-07344-8

4. Su, Q.-Y., Zhang, J.-T., Gao, H.-J., Zhang, Y., Luo, J., Cao, T.-Y., Yang, M.-Y., & Zhang, S.-X. (2025). Mechanism and clinical utility of abatacept in the treatment of rheumatoid arthritis. Expert Opinion on Drug Metabolism & Toxicology.
https://doi.org/10.1080/14740338.2025.2505542

5. Fu, T., Zhang, W., Zhang, S., & Tian, F. (2025). The impact of sleep on the Th17/Treg axis and cytokine levels in patients with major depressive disorder. Neuroscience Research.
https://doi.org/10.1016/j.neures.2025.104927

 

 

Patrizia Leone | Autoimmune Diseases | Research Excellence Award

Dr. Patrizia Leone | Autoimmune Diseases | Research Excellence Award

University of Bari Aldo Moro | Italy

Dr. Patrizia Leone is a physician–scientist affiliated with the Scuola di Medicina, Bari, Italy, with recognized expertise in immunology, connective tissue diseases, vascular biology, and translational medicine. Her research spans autoimmune disorders, endothelial dysfunction, tumor microenvironment, pulmonary arterial hypertension, and immune mechanisms in chronic inflammatory diseases. She has authored 66 peer-reviewed publications, receiving over 2,321 citations, with an h-index of 28, reflecting sustained scientific impact and influence. Dr. Leone has collaborated extensively with international researchers, contributing to multidisciplinary studies that bridge basic science and clinical application. Her work has advanced understanding of immune dysregulation and vascular pathology, supporting improved diagnostic strategies and therapeutic approaches. Through high-impact reviews, original research, and editorial contributions, she continues to shape global discourse in immunology and rheumatology with meaningful societal and clinical relevance.

Citation Metrics (Scopus)

2321
1800
1200
300
0

Citations

2,321

Documents

66

h-index

28

Citations

Documents

h-index

View Scopus Profile

Top 5 Featured Publications

Maysa Eshmawi | Immunological Disease | Best Researcher Award

Dr. Maysa Eshmawi | Immunological Disease | Best Researcher Award 

Dermatosurgery consultant | Saudi Ministry of Health | Saudi Arabia

Dr. Maysa Tariq Eshmawi is a distinguished Consultant in Dermatology, Cosmetic, and Dermatologic Surgery based in Jeddah, Saudi Arabia, affiliated with the Ministry of Health and King Abdullah Medical Complex. She holds prestigious qualifications including an MBBS and Saudi and Arab Boards in Dermatology, as well as dual Fellowships in Cosmetic Dermatology and Phototherapy from Mount Sinai Medical Center, New York, USA. Additionally, she earned Postgraduate Diplomas in Healthcare Management and Strategic Leadership from eduQual, UK. As the Head of the Dermatology Specialty Department at the Saudi MOH, Dr. Eshmawi has spearheaded numerous national initiatives, including the establishment of dermatology registries, development of national clinical guidelines, and authorship of the acclaimed Illustrated Manual for Creating Standard Dermatology Clinics. She serves on multiple national and international committees such as the Saudi Society of Dermatology and Dermatologic Surgery, SFDA Scientific Advisory Committee, and Arab Council of Dermatology and Dermatosurgery, and represents Saudi Arabia in global dermatological forums. A prolific contributor to research and medical education, she has been a speaker, moderator, and chairperson at major conferences like JeddaDerm and SAAM, and continues to train dermatology professionals nationwide. Her commitment to innovation earned her the MOH Pioneer Award and several certificates of appreciation. Dr. Eshmawi has authored and reviewed numerous scientific papers, achieving 10 publications, 35 citations, and an h-index of 4, reflecting her academic impact and leadership in advancing dermatologic science and healthcare standards in Saudi Arabia and beyond.

Featured Publications

1. Cheng, T. A., Mzahim, B., Koenig, K. L., Alsugair, A., Al-Wabel, A., Almutairi, B. S., et al. (2020). Scabies: Application of the novel Identify-Isolate-Inform Tool for detection and management. Western Journal of Emergency Medicine, 21(2), 191.
Cited by: 30

2. Fatani, M. I. A., Alkhalifah, A., Alruwaili, A. F. S., Alharbi, A. H. S., Alharithy, R., et al. (2023). Diagnosis and management of alopecia areata: A Saudi expert consensus statement (2023). Dermatology and Therapy, 13(10), 2129–2151.
Cited by: 15

3. Fatani, M. I., Al Sheikh, A. A., Alajlan, M. A., Alharithy, R. S., Binamer, Y., et al. (2022). National Saudi consensus statement on the management of atopic dermatitis (2021). Dermatology and Therapy, 12(7), 1551–1575.
Cited by: 14

4. Elezbawy, B., Fasseeh, A. N., Fouly, E., Tannira, M., Dalle, H., Aderian, S., et al. (2023). Humanistic and economic burden of atopic dermatitis for adults and adolescents in the Middle East and Africa region. Dermatology and Therapy, 13(1), 131–146.
Cited by: 13

5. Fatani, M. I. A., Hamadah, I. R. A., Alajlan, M. A., Binamer, Y., Alharbi, A. H. S., et al. (2022). Saudi consensus statement on biologic treatment of chronic plaque psoriasis (2020). Journal of Dermatological Treatment, 33(4), 1916–1930.
Cited by: 8

Behablom Meharenet | Immunology | Best Researcher Award

Dr. Behablom Meharenet | Immunology | Best Researcher Award 

Senior Researcher at Animal Health Institute, Ethiopia

Dr. Behablom Meharenet is a distinguished Ethiopian veterinarian and senior researcher at the Animal Health Institute. His expertise spans parasitology, public health, entomology, and immunology, with a special focus on Human and Animal African Trypanosomiasis. He has played a pivotal role in advancing national disease control programs, combining scientific innovation with practical field applications. Known for his problem-solving approach, he has led impactful projects targeting tsetse fly control and livestock disease management. His publications in reputable journals have informed both veterinary and public health strategies, benefiting rural communities dependent on livestock. Dr. Meharenet’s leadership extends beyond research to capacity building, fostering collaboration between scientists, government agencies, and international partners. His dedication to addressing neglected tropical diseases has enhanced Ethiopia’s position in global health research. Through his work, he continues to promote sustainable livestock health solutions that improve livelihoods and contribute to national food security and economic development.

Professional Profile

Scopus

Education

Dr. Behablom Meharenet holds advanced academic qualifications that provide a solid foundation for his research and professional practice. He earned his Doctor of Veterinary Medicine from Hawassa University, where he built expertise in animal health and disease management. To expand his understanding of public health systems and disease prevention, he pursued a Master’s in Public Health at Addis Ababa Medical and Business College. His academic journey also includes specialized training in parasitology, epidemiology, and immunology, equipping him to address complex veterinary and public health challenges. Through research fellowships and professional development programs, he has strengthened his skills in laboratory diagnostics, vector control, and epidemiological survey techniques. His educational achievements have not only enhanced his technical abilities but also fostered a multidisciplinary approach to problem-solving. By integrating veterinary medicine and public health principles, Dr. Meharenet is able to design and implement effective strategies that safeguard both human and animal populations from infectious diseases.

Experience

Dr. Behablom Meharenet has extensive professional experience as a senior researcher, consultant, and project leader in veterinary and public health fields. At the Animal Health Institute, he has overseen national strategies for controlling Human and Animal African Trypanosomiasis, integrating vector control, field epidemiology, and community engagement. His role includes designing and executing experimental trials, such as optimizing sterile insect technique applications for tsetse control. He has led numerous epidemiological studies assessing disease prevalence, vector distribution, and associated risk factors across Ethiopia. Beyond technical research, he has managed multi-stakeholder collaborations with international organizations, ensuring research outcomes translate into practical policy recommendations. His work has improved livestock health, increased rural productivity, and strengthened national capacity to respond to disease threats. Through editorial and peer-review contributions to scientific journals, he has influenced research quality standards. His combined leadership, technical expertise, and field experience make him a recognized authority in vector-borne livestock disease control.

Research Focus

Dr. Behablom Meharenet’s research centers on the epidemiology, prevention, and control of vector-borne diseases, particularly trypanosomosis affecting both humans and animals. His studies investigate disease prevalence, vector biology, and environmental factors influencing transmission. By integrating laboratory diagnostics, field surveys, and intervention trials, he develops strategies for sustainable disease control. His work on tsetse fly population management, including the application of sterile insect techniques, has contributed to innovative approaches in vector suppression. He also explores co-infections such as fascioliasis, providing a broader understanding of disease interactions in livestock. His research addresses the socio-economic impacts of animal diseases, emphasizing the importance of disease-free livestock for rural livelihoods. Collaborations with international agencies strengthen the application of his findings in real-world settings. His multidisciplinary approach combines veterinary medicine, entomology, and public health principles, ensuring that his research outcomes are relevant, scalable, and effective in improving animal health and community well-being.

Publication Top Notes

Title: Implemented strategic trypanosomosis and vector control activities along the Birbir River Basin through the application of deltamethrin-based insecticides using stationary attractive devices (targets), ground spraying, and live bait techniques

Summary:
A baseline and intervention study was conducted from September 2016 to February 2018 measuring entomological and parasitological indicators. After implementing vector control using deltamethrin-treated stationary targets, ground spraying, and live bait techniques, the apparent fly density dropped from 2.61 to 1.68 flies/trap/day (−64.37%). The prevalence of bovine trypanosomosis declined from 7.91% to 4.81% (−60.81%), accompanied by improved mean packed cell volume (PCV) in infected cattle (from 21.87 ± 4.57 to 22.53 ± 4.48 and from 25.41 ± 4.27 to 25.68 ± 4.04). These results demonstrate effective suppression of both vector population and parasite prevalence through the implemented strategies

Conclusion

Dr. Behablom Meharenet exemplifies the blend of academic excellence, field expertise, and practical innovation required to address complex veterinary and public health challenges. His career demonstrates a commitment to both scientific advancement and societal benefit. By tackling neglected tropical diseases such as trypanosomosis, he contributes directly to improving food security, rural livelihoods, and national economic stability. His leadership in multi-disciplinary teams ensures that research findings are translated into actionable strategies adopted by policymakers and implemented in communities. Through partnerships with local and international stakeholders, he fosters sustainable solutions to persistent animal health problems. His editorial and peer-review roles reflect his dedication to maintaining high research standards in the scientific community. Driven by a vision of healthier livestock and resilient communities, Dr. Meharenet continues to advance research that bridges the gap between science and practice, making him a strong candidate for the Best Researcher Award.